 | Recent Bibliography
 | Papers
 | Armenti VT, Herrine SK, Radomski JS, Moritz MJ. Pregnancy
after liver transplantation. Liver Transplantation.
2000;6:671-685. |
| Baig N, Herrine SK, Rubin R. Liver Disease in Diabetes
Mellitus. Clinics of Laboratory Medicine. 2001;21:1,
193-207. |
| Herrine, SK. The epidemiology of hepatitis C virus in the
United States. Infections in Medicine, 1999;16:111-117.
|
| Nazarian LN, Feld RI, Herrine SK, Webner D, Lev-Toaff AS,
Johnson PT, Storey LA, Needleman L. Safety and efficacy of
sonographically guided random core biopsy for diffuse liver
disease. J Ultrasound Med. 2000;19:537-541. |
| Herrine SK. Approach to the Patient with Chronic Hepatitis
C. Ann Intern Med 2002;136:747-57 |
| Zhang X-M, Mitchell DG, Shi H, Holland GA, Parker L,
Herrine SK, Pasqualin D, Rubin R. Chronic hepatitis C
activity: correlation with lymphadenopathy on MR imaging.
American Journal of Radiology(AJR). 2002;179:1-6 |
|
| Book Chapters
| Herrine SK, Muñoz SJ. Lebertransplantation - Indikationen,
Vorbereitung und Langzeitbetreuung [Liver Transplantation:
indications, preparations and long term management]. In Hahn
EG, Riemann JF, editors. Klinische Gasroenterologie.
Stuttgart: Georg Thieme Verlag, 1996. |
| Herrine SK, Zern, MA. Alpha-1-Antitrypsin Deficiency. In
Wu GY and Israel J., eds. Diseases of the Liver and Bile
Ducts. Totowa, NJ: Humana Press, 1998. |
| Herrine SK, Runyon, BA. Paracentesis. In Merli G, DiMarino
AJ. eds. Clinics Atlas of Office Procedures. Philadelphia, PA:
Saunders, 1999. |
| Herrine SK, Muñoz SJ. Lebertransplantation - Indikationen,
Vorbereitung und Langzeitbetreuung [Liver Transplantation:
indications, preparations and long term management]. In Hahn
EG, Riemann JF, editors. Klinische Gastroenterologie: in 2
B”nden. Stuttgart: Georg Thieme Verlag, 2000 |
| Zamani S, Herrine SK. Viral Hepatitis. In Edmundowicz SA,
ed. 20 Common Problems in Gastroenterology. New York,
McGraw-Hill, 2002 |
|
| Abstracts
| Herrine SK, Weinberg DS. Education intervention improves
practitioners' knowledge of hepatitis C infection.
Hepatology 1999;30:483A. |
| Chojnacki KA, Radomski JS, Rubin R, Moritz MJ, Armenti VT,
Wilson GA, Conn MI, Herrine SK. Results of liver
transplantation for nodular regenerative hyperplasia.
Hepatology 1999;30:660A. |
| Sjogren MH, Wu G, Herrine SK., Raufman JP, Bacon BR,
Epstein M, Medoff J, Chen S, Waters B, Krawitt E, Sjogren RW,
Herrera J. Efficacy of Interferon Alfacon-1 in non-responders
and relapsers to interferon and ribavirin. Gastoenterology.
2000;1188:6738A.. |
| Michael B, Dunn SR, Ma W, Herrine SK. Analysis of liver
function in hemodialysis patients with anti-HCV antibody.
Journal of the American Society of Nephrology
2000;11:288A. |
| Herrine SK, Weinberg DS, Greenfield SM, Shaw EW.
Interferon alpha-2b/ribavirin in both high and standard dose
induces sustained response in previous interferon monotherapy
non-responders. Hepatology 2000;32:352A. |
| Sjogren MH, Wu G, Herrine SK., Raufman JP, Bacon BR,
Epstein M, Medoff J, Chen S, Waters B, Krawitt E, Sjogren RW,
Herrera J. High-dose Interferon Alfacon-1 is a treatment
option for non-responders and relapsers to combined therapy
with interferon and ribavirin. Hepatology 2000;32:352A.
|
| Herrine SK, Brown R; Esposito S; Lok A; Galati JS;
Bernstein DE; Campagna J, Pappas SC. Pegylated (40 kda)
interferon alfa-2a (Pegasys) in combination with ribavirin,
mycophenolate mofetil, amantadine, or amantadine plus
ribavirin in patients that relapsed on rebetron therapy: a
preliminary report of a randomized, multicenter efficacy and
safety study. Gastroenterology. 2001;120:384A. |
| Kolodziejski TR, Rubin R, Stefanosky E, Herrine SK.
End-stage renal disease patients with chronic hepatitis C
infection undergoing renal transplant evaluation have mild
hepatic histology. Hepatology. 2001;34:568A |
| Ma W, Rossi S, Michael B, Dunn S, Hyslop T, Herrine SK.
Development of a HCV risk stratification algorithm for
patients of chronic hemodialysis. Hepatology. 2001;34:574A
|
| Afdhal N, Flamm S, Imperial JC, Malet PF, Tong M, Herrine
SK, Brown R, Espositio S, Bernstein DE, Campagna JL. Analyses
of 40kDa peginterferon alfa-2a (Pegasys) in combination
withribavirin, mycophenolate mofetil, amantadine, or
amantadine plus ribavirinin patients that relapsed or did not
respond to Rebetron therapy: a report of two randomized,
multicenter, efficacy and safety studies. Hepatology.
2001;34:243A |
| Sapienza MS, Herrine SK, Porayko, MP, Rubin R, DiMarino,
AJ, Weinberg DS. A pilot study to assess the effect of
targeted COX-2 inhibition on liver histology in patients
infected with hepatitis C virus. Gastroenterology.
2002;122:P-21 |
|
|
